In the future, we will also need to further investigate the combination therapy of BTK inhibitors with other anti-tumor drugs in order to increase the anti-tumor efficacy and prevent the adverse reactions that are caused by non-selective inhibition by BTK inhibitors. The gene discussed is BTK; the disease is neoplasm.